Evidence map›Paper›PMID 29613975›Full record

Trial reportThe Pediatric infectious disease journal2019

Antibiotic Overuse in Premature Low Birth Weight Infants in a Developing Country.

Maria S Rueda, Renzo Calderon-Anyosa, Jorge Gonzales, Christie G Turin, Alonso Zea-Vera, Jaime Zegarra, Sicilia Bellomo, Luis Cam, Anne Castaneda, Theresa J Ochoa and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The Pediatric infectious disease journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Pay particular attention to the use of antibiotics in preterm infants with early-onset sepsis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Maria S RuedaFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Renzo Calderon-AnyosaFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Jorge GonzalesFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Christie G TurinFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Alonso Zea-VeraFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Jaime ZegarraFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Sicilia BellomoFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
Luis CamHospital Nacional Alberto Sabogal Sologuren, Lima, Peru.
Anne CastanedaHospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
Theresa J OchoaFrom the Universidad Peruana Cayetano Heredia, Lima, Peru.
NEOLACTO Research Group
Universidad Peruana Cayetano Heredia · PEHospital Base Guillermo Almenara Irigoyen · PEHospital Nacional Cayetano Heredia · PEInstituto Nacional de Salud del Niño · PE

Funding

Lactoferrin for prevention of sepsis in infantsR01HD067694 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI OCHOA, THERESA J · 2011 to 2015
$2.0M
NICHD NIH HHS R01 HD067694
6 · The paper itself

Abstract

backgroundNeonatal sepsis is a leading cause of child morbidity and mortality, especially in premature and low birth weight infants. Prompt antibiotic therapy is warranted, but its inappropriate use leads to bacterial resistance and adverse outcomes. Our objective is to describe the antibiotic use for late-onset sepsis in Peruvian premature infants.

methodsThis study is a prospective study as a secondary analysis of a clinical trial in 3 neonatal care units in Peru. We included infants in the first 72 hours of life, with birth weight (BW) <2000 g. We described the antibiotic use as length of therapy (LOT) per 1000 patient days (PD) and antibiotic courses.

resultsWe included 408 neonates, with 12,204 PD of follow-up; 253 infants (62%) had a BW ≤1500 g. Total antibiotic use for late-onset sepsis was 2395 LOT (196 LOT/1000 PD). Two-hundred and seventy-one patients (66.4%) did not receive antibiotics for late-onset sepsis during their hospitalization. In total, 204 antibiotic courses were administered; 92 infants (22.5%) received 1 course, and 45 (11.0%) received 2-5 antibiotic courses. Mean duration of antibiotic course was 10.8 days (standard deviation: ±7.3). We found a significant association between a lower BW and increased antibiotic use per day (P < 0.001). The most commonly used antibiotics were vancomycin (143 LOT/1000 PD), carbapenems (115 LOT/1000 PD), aminoglycosides (72 LOT/1000 PD) and ampicillin (41 LOT/1000 PD).

conclusionsPremature infants receive antibiotics for longer than recommended periods of time. Antibiotic overuse is greater in neonates with lower BW. Vancomycin is the most used antibiotic. There is an urgent need to develop antimicrobial stewardship programs in our setting.

Indexed as

Infant, PrematureAnti-Bacterial AgentsBacterial InfectionsBirth WeightDeveloping CountriesDouble-Blind MethodFemaleHumansInfant, NewbornInfant, Premature, DiseasesInfant, Very Low Birth WeightIntensive Care Units, NeonatalMaleNeonatal SepsisPeruPregnancyAnti-Bacterial Agents

Identifiers

PMID29613975
PMCPMC6168436
OpenAlexW2795636976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.